For following the competition: what moved in each program, several studies read as one move.
- Anti-EGFR/Anti-c-Met Bispecific Antibody-drug Conjugate VBC101
- VBC103
- VBC106
- + 2 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add VelaVigo Cayman to watchlistEvery Monday by email · turn it off any timePro · free during the beta